These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18279745)

  • 1. Switching thienopyridines: hypothetical versus real risks.
    Serebruany VL
    J Am Coll Cardiol; 2008 Feb; 51(7):775; author reply 75-6. PubMed ID: 18279745
    [No Abstract]   [Full Text] [Related]  

  • 2. Clopidogrel resistance: a new chapter in a fast-moving story.
    Wiviott SD; Antman EM
    Circulation; 2004 Jun; 109(25):3064-7. PubMed ID: 15226220
    [No Abstract]   [Full Text] [Related]  

  • 3. Variable therapeutic effectiveness of clopidogrel in acute coronary syndromes.
    Heptinstall S
    J Thromb Haemost; 2006 Mar; 4(3):539-41. PubMed ID: 16405519
    [No Abstract]   [Full Text] [Related]  

  • 4. High postclopidogrel platelet reactivity in non-ST-elevation acute coronary syndrome treated with stenting: a clue for adverse prognosis?
    Galvani M
    J Thromb Haemost; 2006 Mar; 4(3):536-8. PubMed ID: 16460436
    [No Abstract]   [Full Text] [Related]  

  • 5. Durability of platelet inhibition by clopidogrel.
    Gurbel PA; Bliden KP
    Am J Cardiol; 2003 May; 91(9):1123-5. PubMed ID: 12714161
    [No Abstract]   [Full Text] [Related]  

  • 6. Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study.
    Campo G; Valgimigli M; Gemmati D; Percoco G; Catozzi L; Frangione A; Federici F; Ferrari F; Tebaldi M; Luccarelli S; Parrinello G; Ferrari R
    J Am Coll Cardiol; 2007 Sep; 50(12):1132-7. PubMed ID: 17868803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet reactivity and stent thrombosis: still some issues to solve.
    Perez de Prado A; Cuellas C; Diego A; de Miguel A; Fernandez-Vazquez F
    J Am Coll Cardiol; 2009 Aug; 54(7):666-7; author reply 667-8. PubMed ID: 19660707
    [No Abstract]   [Full Text] [Related]  

  • 8. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study.
    Gurbel PA; Bliden KP; Zaman KA; Yoho JA; Hayes KM; Tantry US
    Circulation; 2005 Mar; 111(9):1153-9. PubMed ID: 15738352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time dependence of clopidogrel loading effect: platelet activation versus platelet aggregation.
    Gurbel PA; Bliden KP; Antonino MJ; Gesheff T; Cummings CC; Dubois BV; Herzog WR; Tantry US
    Thromb Res; 2012 Jan; 129(1):1-2. PubMed ID: 21862113
    [No Abstract]   [Full Text] [Related]  

  • 10. What is the best measure of thrombotic risks--pretreatment platelet aggregation, clopidogrel responsiveness, or posttreatment platelet aggregation?
    Tantry US; Bliden KP; Gurbel PA
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):597-8. PubMed ID: 16208713
    [No Abstract]   [Full Text] [Related]  

  • 11. Triple antiplatelet therapy for clopidogrel resistance with stent malapposition: a case report.
    Ding FH; Zhang Q; Zhang RY; Hu J; Shen J; Zhao LP; DU R; Zhang X; Shen WF
    Chin Med J (Engl); 2009 Sep; 122(18):2186-8. PubMed ID: 19781309
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimizing platelet inhibition in clopidogrel poor metabolizers: therapeutic options and practical considerations.
    Angiolillo DJ; Ueno M
    JACC Cardiovasc Interv; 2011 Apr; 4(4):411-4. PubMed ID: 21511220
    [No Abstract]   [Full Text] [Related]  

  • 13. Bedside evaluation of thienopyridine antiplatelet therapy.
    Price MJ
    Circulation; 2009 May; 119(19):2625-32. PubMed ID: 19451364
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance to antiplatelet drugs: is it real or relevant?
    Berger PB
    Catheter Cardiovasc Interv; 2004 May; 62(1):43-5. PubMed ID: 15103602
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to antiplatelet resistance is it justified?
    Steinhubl SR; Charnigo R; Moliterno DJ
    J Am Coll Cardiol; 2005 Jun; 45(11):1757-8. PubMed ID: 15936601
    [No Abstract]   [Full Text] [Related]  

  • 16. [Routine platelet aggregation inhibition not useful when using acetylsalicylic acid or clopidogrel].
    Kramer MC; Nieuwland R; Sturk A; de Winter RJ
    Ned Tijdschr Geneeskd; 2009 Jan; 153(5):190-5. PubMed ID: 19256247
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.
    Trenk D; Hochholzer W; Fromm MF; Chialda LE; Pahl A; Valina CM; Stratz C; Schmiebusch P; Bestehorn HP; Büttner HJ; Neumann FJ
    J Am Coll Cardiol; 2008 May; 51(20):1925-34. PubMed ID: 18482659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation.
    Geisler T; Anders N; Paterok M; Langer H; Stellos K; Lindemann S; Herdeg C; May AE; Gawaz M
    Diabetes Care; 2007 Feb; 30(2):372-4. PubMed ID: 17259513
    [No Abstract]   [Full Text] [Related]  

  • 19. Impaired platelet responses to clopidogrel and ticlopidine in a patient with recurrent coronary stent stenosis.
    Obergfell A; Strotmann J; Bonz A; Bauersachs J; Ertl G; Walter U; Grossmann R
    Thromb Haemost; 2004 Dec; 92(6):1446-7. PubMed ID: 15622617
    [No Abstract]   [Full Text] [Related]  

  • 20. Prasugrel offers consistent platelet control in appropriate patients requiring treatment.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(2):107, 109. PubMed ID: 21556460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.